Assessment of drug resistance to the malaria parasite in residents of Kampala, Uganda

East African Medical Journal

Volumn 76, Issue 8, 1999, Pages 421-424

  Mutanda, L N ^a  

^a Central Public Health Laboratory   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; QUININE;

AFRICA; AFRICA SOUTH OF THE SAHARA; ARTICLE; BLOOD; DEVELOPING COUNTRY; DISEASES; DRUGS--THERAPEUTIC USE; EASTERN AFRICA; ENGLISH SPEAKING AFRICA; EXAMINATIONS AND DIAGNOSES; HEALTH; HUMAN; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; MALARIA; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; PARASITOLOGY; PARASITOSIS; RESEARCH REPORT; TREATMENT; UGANDA;

AFRICA; AFRICA SOUTH OF THE SAHARA; DEVELOPING COUNTRIES; DISEASES; DRUGS--THERAPEUTIC USE; EASTERN AFRICA; ENGLISH SPEAKING AFRICA; EXAMINATIONS AND DIAGNOSES; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; MALARIA; PARASITIC DISEASES; RESEARCH REPORT; TREATMENT; UGANDA;

ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE, MULTIPLE; HUMANS; MALARIA, FALCIPARUM; QUININE; UGANDA; URBAN HEALTH;

EID: 0033238210     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bjorkman, A. and Phillip-Howard, P.A. The epidemiology of drug - resistant malaria. Trans. roy. Soc. trop. Med. Hyg. 1990; 84:177-80.
2. Pettersson, T. Kyronseppa, H. and Pitkamen, T. Chloroquine resistant falciparum malaria from E. Africa. Trans. roy. Soc. trop. Med. Hyg. 1981; 75:112-113.
3. Hellgren, U., Johansson, I. Dias, Ferissson, O. Stenbeck, J. and Rombo, L. Chloroquine resistant Plasmodium falciparum malaria in Guinea-Bissau. Trans. roy. Soc. trop. Med Hyg. 1991; 85:36.
4. Gascon, J. Soldevila Merlos, A. and Bada, J.L. Chloroquine and amodiaquine resistant falcipanun in Rwanda. Lancet. 1985; 1:1072.
5. Awash Teklehaimanot. Chloroquine resistant Plasmodium falciparum malaria in Ethiopia. Lancet. 1986; 1:127-129.
6. Kihamia, C.M. and Gill, H.S. Chloroquine resistant falciparum malaria in semi-immune African Tanzanians. Lancet. 1982; 1:45.
7. Warsame, M. Wernsdorfer, W.H., Payne, D. and Bjorkman, A. Susceptibility of Plasmodum falciparum in vitro to chloroquine, mefloquine, quinine and sulfadoxine/ pyrimethamine in Somalia: relationship between the responses to the different drugs. Trans. roy. Soc. trop. Med. Hyg. 1991; 85:565-569.
8. Wernsdorfer, W.H. Epidemiology of drug resistance in malaria. Acta Trop. 1994; 56:143-156.
9. Mutanda, L.N. Selected laboratory tests in febrile patients in Kampala, Uganda. East Afr. Med. J. 1998; 75:68-72.
10. Clyde, D.F. Miller, R.M. Dupont, H.L. and Hornick, RIB. Treatment of falciparum malaria caused by a strain resistant to quinine. J. Amer. Med. Ass. 1970; 213:2041-45.
11. World Health Organization. Chemotherapy of malaria; (Ed.) Brucechwatt L.J. 1981b; PP 109-110, Geneva WHO.
12. Gozal, D and Hengy, C. Treatment of malaria with Sulfadoxine/ Pyrimethamine: Note of caution. Lancet. 1998; 336:111-112.
13. Brasseur, P. Kouamouo, J., Moyou-Somo, R. and Druithe, P. Multi drug resistant falciparum malaria in Cameroon in 1987-1988. I. Stable figures of prevalence of chloroquine and quinine resistance isolates in the original foci. Amer. J. trop. Med. Hyg. 1992; 46: 1-7.
14. Verdrager J. Observations of the longavity of Plasmodium falciparum with special reference to findings in Mauritius. Bull WHO 1964; 31:747-751.
15. Short, H.E. Relapse in primate malaria. Trans. roy. Soc. trop. Med. Hyg. 1981, 75:320-321.
16. Kremsner, P.G. Winklers, S. Wilding, E. Prada, J. Bienzle, U. Graininger, W. et al. High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum. Trans. roy. Soc. trop. Med. Hyg. 1996; 90:44-47.